Full Version | Search

The Irish Medicines Board - www.imb.ie

IMB Logo

Vectibix (panitumumab) - Important Safety Information from Amgen as approved by the Irish Medicines Board

26 April 2010

Important Safety Information communication from Amgen on serious hypersensitivity including anaphylaxis and angiodema.

Important Safety Information - Vectibix (panitumumab)





Date Printed: 20 May 2013

© Irish Medicines Board 2013 | Developed by Engine Solutions www.engine.ie

Address: Kevin O'Malley House, Earlsfort Centre, Earlsfort Terrace, Dublin 2, Ireland.
Tel: 353-1-676 4971